CXCL2, C-X-C motif chemokine ligand 2, 2920

N. diseases: 186; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4529962
Disease: Fatty Liver Disease
Fatty Liver Disease
0.010 AlteredExpression disease BEFREE In this study, we evaluated the therapeutic effect of the synthetic miR-223 analog miR-223 3p in a murine model of lipopolysaccharide (LPS)/D-GalN-induced endotoxin acute hepatitis (EAH) or fibrotic NASH resultant of long-term feeding with a high-fat, fructose, and cholesterol (FFC) diet. miR-223 3p ameliorated the infiltration of monocytes, neutrophils, and early activated macrophages and downregulated the transcriptional expression of the pro-inflammatory cytokines Il6 and Il12 and the chemokines Ccl2, Ccl3, Cxcl1, and Cxcl2 in EAH. 31585800 2020
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 Biomarker disease BEFREE Our results suggest that DN is an effective inducer of HO-1 in the pancreas, and that HO-1 regulates neutrophil infiltration in AP via CXCL2 inhibition. 30738992 2019
CUI: C0007222
Disease: Cardiovascular Diseases
Cardiovascular Diseases
0.010 Biomarker group BEFREE This review aims to investigate the expression changes of CXCL2 in acute myocardial infarction (AMI), atherosclerosis (AS), obesity, diabetes and ischemic stroke (IS) and its potential key role in cardiovascular disease in order to provide new ideas for the prevention and treatment of cardiovascular diseases. 31752549 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.010 AlteredExpression disease BEFREE CXCL1/CXCL2 expression was correlated with depression-like behaviors in response to chronic stress or antidepressant treatment in the UCMS depression model. 31034777 2019
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 AlteredExpression disease BEFREE CXCL1/CXCL2 expression was correlated with depression-like behaviors in response to chronic stress or antidepressant treatment in the UCMS depression model. 31034777 2019
CUI: C0020725
Disease: Type II Mucolipidosis
Type II Mucolipidosis
0.010 AlteredExpression disease BEFREE NoE and NoE gel reduced the pro-inflammatory cytokines levels (acute ICD model) by 62 ± 5% and 71 ± 3% (MIP-2) and 32 ± 3% and 44 ± 4% (IL-1β), while dexamethasone solution's and gel reduced by 79 ± 7% and 44 ± 4% to MIP-2 and 98 ± 2% and 83 ± 9% to IL-1β, respectively. 30339978 2019
Disruptive, Impulse Control, and Conduct Disorders
0.010 AlteredExpression group BEFREE NoE and NoE gel reduced the pro-inflammatory cytokines levels (acute ICD model) by 62 ± 5% and 71 ± 3% (MIP-2) and 32 ± 3% and 44 ± 4% (IL-1β), while dexamethasone solution's and gel reduced by 79 ± 7% and 44 ± 4% to MIP-2 and 98 ± 2% and 83 ± 9% to IL-1β, respectively. 30339978 2019
CUI: C0021400
Disease: Influenza
Influenza
0.010 AlteredExpression disease BEFREE Our findings support the conclusion that selective suppression of CXCL1/CXCL2 represents an IFN-β-mediated "training" of the macrophage transcriptional response to TLR2 agonists and that blocking of TLR4 therapeutically with Eritoran after influenza virus infection reverses this suppression by blunting influenza-induced IFN-β. 31064834 2019
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.010 Biomarker disease BEFREE PLAG significantly decreased plasma levels of the chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL2, interleukin (IL)-6, and C-reactive protein (CRP), which were elevated consistently with the occurrence time of neutropenia, monocytopenia, and thrombocytopenia. 31752148 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker disease BEFREE DNA microarray and mRNA expression analyses revealed that the upregulation of genes involved in inflammatory processes and cell motility of leukocytes and neutrophils, including Mmp9, Il1b, Cxcl2, and Nlrp3, was significantly attenuated in MAFbx KO mice 1 day after MI. 30408466 2019
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 Biomarker phenotype BEFREE Our results show that IL-10 or anti-CXCL2 are therapy options for neuropathic pain. 30904573 2019
CUI: C0027947
Disease: Neutropenia
Neutropenia
0.010 Biomarker disease BEFREE PLAG significantly decreased plasma levels of the chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL2, interleukin (IL)-6, and C-reactive protein (CRP), which were elevated consistently with the occurrence time of neutropenia, monocytopenia, and thrombocytopenia. 31752148 2019
CUI: C0029453
Disease: Osteopenia
Osteopenia
0.010 Biomarker disease BEFREE CXCL2 neutralization within the bone marrow by using antibody alleviated bone loss in mice, indicating a negative role of CXCL2 in bone formation. 31292171 2019
CUI: C0040034
Disease: Thrombocytopenia
Thrombocytopenia
0.010 Biomarker phenotype BEFREE PLAG significantly decreased plasma levels of the chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL2, interleukin (IL)-6, and C-reactive protein (CRP), which were elevated consistently with the occurrence time of neutropenia, monocytopenia, and thrombocytopenia. 31752148 2019
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.010 AlteredExpression disease BEFREE This review aims to investigate the expression changes of CXCL2 in acute myocardial infarction (AMI), atherosclerosis (AS), obesity, diabetes and ischemic stroke (IS) and its potential key role in cardiovascular disease in order to provide new ideas for the prevention and treatment of cardiovascular diseases. 31752549 2019
CUI: C0260037
Disease: Multiple tumors
Multiple tumors
0.010 AlteredExpression phenotype BEFREE In addition, tumors with higher CXCL2 expression included significantly more numbers of multiple tumors than the lower expression group. 30564899 2019
CUI: C0262469
Disease: Embolic stroke
Embolic stroke
0.010 Biomarker disease BEFREE Staphylococcus aureus infected embolic stroke upregulates Orm1 and Cxcl2 in a rat model of septic stroke pathology. 30707086 2019
CUI: C0276289
Disease: Zika Virus Infection
Zika Virus Infection
0.010 Biomarker disease BEFREE To investigate whether antigenic SG proteins are capable of enhancing infection with Zika virus (ZIKV), a reemerging flavivirus primarily transmitted by the <i>Aedes aegypti</i> mosquito, we screened for antigenic SG proteins using a yeast display library and demonstrate that a previously undescribed SG protein we term neutrophil stimulating factor 1 (NeSt1) activates primary mouse neutrophils <i>ex vivo</i> Passive immunization against NeSt1 decreases pro-interleukin-1β and CXCL2 expression, prevents macrophages from infiltrating the bite site, protects susceptible IFNAR<sup>-/-</sup> IFNGR<sup>-/-</sup> (AG129) mice from early ZIKV replication, and ameliorates virus-induced pathogenesis. 30971475 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.010 AlteredExpression phenotype BEFREE CXCL1/CXCL2 expression was correlated with depression-like behaviors in response to chronic stress or antidepressant treatment in the UCMS depression model. 31034777 2019
CUI: C0406810
Disease: Carney Complex
Carney Complex
0.010 Biomarker disease BEFREE In DfAf mice, ITCZ and LAMB significantly decreased the elevation of MIP-2 (p < 0.05 vs the DfAf group). 31396817 2019
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.010 Biomarker phenotype BEFREE Depletion of monocytes and neutrophils caused increased serum concentrations of TNF, IL-6, and MIP-2 in TVX-treated mice as well as in mice treated with the fluoroquinolone levofloxacin, known to have a lower DILI-inducing profile. 30247740 2019
Transfusion-Related Acute Lung Injury
0.010 Biomarker disease BEFREE The OPN-mediated TRALI response seemed dependent on macrophages, likely the cellular source of OPN and OPN polymerization, and independent from the OPN receptor CD44, interleukin 6 (IL-6), and other PMN chemoattractants including macrophage inflammatory protein-2 (MIP-2). 31076444 2019
CUI: C1136033
Disease: Cutaneous Mastocytosis
Cutaneous Mastocytosis
0.010 AlteredExpression disease BEFREE From the analysis of the data, we found that showed that Cm infection could upregulate the expression of neutrophil-related chemokines such as KC, MIP-2 and IL-6, as well as adhesion molecules including ICAM-1 and VCAM-1. 30703475 2019
CUI: C3280586
Disease: Mannose-Binding Protein Deficiency
Mannose-Binding Protein Deficiency
0.010 Biomarker disease BEFREE Mechanistic studies established that MBL deficiency caused increased chemokine CXCL2 production from liver macrophages upon CCl<sub>4</sub> stimulation, thereby promoting the hepatic recruitment of neutrophils and subsequent liver damage. 30351498 2019
CUI: C4704753
Disease: Urinary Bladder, Underactive
Urinary Bladder, Underactive
0.010 AlteredExpression phenotype BEFREE Mechanistically, the expression of purinergic receptor P2X-1 was reduced in the AI-30 group, and the genome-wide gene expression analysis revealed that genes related to IL-17 and HIF-1 signaling pathways including INF-γ receptor-1 and C-X-C motif chemokine ligand-2 were upregulated in the CBI-induced DUA rat model. 31705030 2019